Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

SETDB1 is essential for controlling DNA methylation, silencing retrotransposons, and maintaining skin cell health, with its absence leading to skin inflammation and hair loss.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

A new mouse model for vitiligo helps study immune responses and potential treatments.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

Early diagnosis and aggressive treatment are crucial for better outcomes in lymphomatoid granulomatosis.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

A man with a rare lung-focused form of hypereosinophilic syndrome improved with steroid treatment.

A 10-month-old boy with a rare combination of genetic conditions has severe immune deficiency and treatment challenges.

The document concludes that misdiagnosis in skin conditions is common, certain treatments can cause allergic reactions, and some skin symptoms are linked to leukemia, especially in certain Japanese regions.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.